Predictive biomarkers of ICIs, such as PD-L1 expression, combined positive score (CPS), microsatellite instability (MSI), and tumor mutational burden (TMB), are currently used in several types of cancers [48,49,50,51,52]. Here, CD274 is linked to cancer.